HighTower Advisors’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,492
Closed -$124K 3751
2023
Q1
$124K Hold
3,492
﹤0.01% 2894
2022
Q4
$121K Sell
3,492
-266
-7% -$9.36K ﹤0.01% 2911
2022
Q3
$126K Sell
3,758
-784
-17% -$29.1K ﹤0.01% 2717
2022
Q2
$157K Sell
4,542
-1,333
-23% -$49.5K ﹤0.01% 2687
2022
Q1
$253K Hold
5,875
﹤0.01% 2656
2021
Q4
$292K Sell
5,875
-833
-12% -$43.1K ﹤0.01% 2489
2021
Q3
$359K Sell
6,708
-1,734
-21% -$95.8K ﹤0.01% 2296
2021
Q2
$486K Sell
8,442
-6,565
-44% -$373K ﹤0.01% 2070
2021
Q1
$860K Buy
15,007
+6,289
+72% +$385K ﹤0.01% 1662
2020
Q4
$503K Buy
8,718
+3,335
+62% +$179K ﹤0.01% 1646
2020
Q3
$269K Buy
+5,383
New +$260K ﹤0.01% 1894

Other funds holding HEAL

HighTower Advisors's HEAL Position: Q2 2023 in Review

HighTower Advisors sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q2 2023, closing a stake of 3,492 shares — an estimated $124K sold.

HighTower Advisors first reported a position in HEAL in Q3 2020 and held it in 11 quarters. The position peaked at $860K in Q1 2021. 49 funds tracked by Wall St. Rank hold HEAL as of Q2 2023.

  • HighTower Advisors reported no remaining Global X Funds Global X HealthTech ETF position as of Q2 2023 after selling out during the quarter.
  • HighTower Advisors sold 3,492 Global X Funds Global X HealthTech ETF shares in Q2 2023, an estimated $124K.
  • HighTower Advisors first reported a position in Global X Funds Global X HealthTech ETF in Q3 2020 and held it in 11 quarters.
  • HighTower Advisors's Global X Funds Global X HealthTech ETF position peaked at $860K in Q1 2021.
  • 49 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q2 2023.

Based on HighTower Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.